ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0797

Innate Lymphoid Cells Enhance Development of CD4+ T-cell Driven Autoimmune Arthritis

Agnieszka Lastowska1, Charlotte E. van der Plas1, Anders Nguyen1, Symeon Kourmoulakis1, Miriam Bollmann1 and Mattias N.D Svensson2, 1Department of Rheumatology and Inflammation research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 2University of Gothenburg, Gothenburg, Sweden

Meeting: ACR Convergence 2023

Keywords: Animal Model, Experimental Arthritis, Innate Immunity Rheumatic Disease, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: RA – Animal Models

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: Innate Lymphoid cells (ILCs) are innate counterparts to T-cells that, based on their functional phenotype, can be divided into three subpopulations called Group 1 (ILC1), Group 2 (ILC2) and Group 3 (ILC3). ILC subsets in autoimmune and chronic inflammatory diseases have been shown to display altered distribution and function, indicating subset-specific involvement. Although these tissue resident immune cells have been identified in the synovium of patients with rheumatoid arthritis (RA), their role in disease pathogenesis still remains largely unknown. SKG mice, which carry the Zap70W163C point mutation, develop autoimmune arthritis due to a defective negative selection of CD4+ T-cells in thymus. Here, we use the SKG mouse model to further assess the role of ILCs in arthritis development and find that ILCs have an important role in aggravating disease progression.

Methods: Arthritogenic CD4+ SKG T-cells were transferred to T and B cell deficient Rag2-knock out (Rag2-/-) mice to induce development of SKG arthritis. ILC subsets were evaluated in arthritic joints of mice with either spontaneous or mannan- induced SKG arthritis by flow cytometry. The role of ILCs in SKG arthritis was evaluated by transferring CD4+ SKG T-cells to ILC-deficient Rag2 and IL2rg double knockout (Rag2-/-IL2rg-) mice. Additionally, ILCs were isolated by flow cytometry, expanded in vitro and adoptively transferred in combination with CD4+ SKG T-cells into ILC-deficient (Rag2-/-IL2rg-) mice. Development of arthritis was monitored by clinical scoring. Mann-Whitney or un-paired T tests were used for statistical differences.

Results: Phenotypic characterization of ILC subsets in arthritic ankles revealed that ILC2 is the dominant synovial ILC population in joints of mice in both mannan-induced and spontaneous arthritis. ILC1 expanded in joint of mice during both mannan-induced and spontaneous arthritis. However, a synovial presence of ILC3 could only be observed in mice with mannan-induced arthritis. Surprisingly, there was no significant difference in severity between mannan-induced and spontaneous arthritis in Rag2-/- mice after transfer of CD4+ SKG T cells. The role of ILC in SKG arthritis was supported by an alleviated arthritis development in ILC-deficient mice (P=0.041) after transfer with CD4+ SKG T cells. Finally, reconstitution of ILC-deficient mice with ILCs aggravated arthritis development after transfer with CD4+ SKG T cells (P=0.027).

Conclusion: Here we identify that ILC2 is the dominant ILC population in joints of mice with SKG arthritis. In addition, the aggravated development of arthritis in ILC-deficient mice after reconstitution of ILCs demonstrates the pathological effect of ILCs in SKG arthritis. Furthermore, the mannan-specific expansion of ILC3 in arthritic joints, suggest that synovial ILC3 are either directly or indirectly activated by inflammatory signals induced via the lectin pathway. Together, our results show that ILCs play a key role in promoting development of SKG arthritis and that different inflammatory triggers (e.g. mannan) induce unique synovial ILC distribution, which could result in specific synovial pathotypes.


Disclosures: A. Lastowska: None; C. van der Plas: None; A. Nguyen: None; S. Kourmoulakis: None; M. Bollmann: None; M. Svensson: None.

To cite this abstract in AMA style:

Lastowska A, van der Plas C, Nguyen A, Kourmoulakis S, Bollmann M, Svensson M. Innate Lymphoid Cells Enhance Development of CD4+ T-cell Driven Autoimmune Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/innate-lymphoid-cells-enhance-development-of-cd4-t-cell-driven-autoimmune-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/innate-lymphoid-cells-enhance-development-of-cd4-t-cell-driven-autoimmune-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology